Upper GI 2017

Oesophageal Cancer – CROSS Study

Median follow-up for surviving patients: 84·1 months (HR 0·68 [95% CI 0·53–0·88]; log-rank p=0·003)

Shapiro J et al., Lancet Oncol 2015; 16: 1090–98

© Universitätsmedizin Leipzig: University Cancer Center Leipzig (UCCL), Prof. Dr. F. Lordick